Laboratoire de Virologie Médicale et Moléculaire, IFR 53/EA-4303, Faculté de Médecine de Reims, Centre Hospitalier Universitaire de Reims, 51092 Reims Cedex, France.
J Clin Microbiol. 2010 Nov;48(11):3836-42. doi: 10.1128/JCM.00733-10. Epub 2010 Aug 25.
We prospectively tested 95 nasal swabs or nasopharyngeal aspirates taken from 56 adults and 39 children visiting the Reims University Medical Centre (northern France) for influenza-like illnesses (ILI) during the early stage of the French influenza A/H1N1v pandemic (October 2009). Respiratory samples were tested using a combination of two commercially available reverse transcription-PCR (RT-PCR) DNA microarray systems allowing rapid detection of influenza A virus strains, including the new A/H1N1v strain as well as 20 other common or newly discovered respiratory viruses. Concomitantly, a generic and classical real-time RT-PCR assay was performed to detect all circulating influenza A virus strains in the same samples. Of the 95 respiratory samples tested, 30 (31%) were positive for the detection of influenza A/H1N1v virus infection by both RT-PCR DNA microarray and classical real-time RT-PCR detection assays. Among the infections, 25 (83%) were monoinfections, whereas 5 (17%) were multiple infections associating influenza A/H1N1v virus with coronavirus (CoV), human bocavirus (HBoV), respiratory syncytial virus (RSV), or human rhinoviruses (HRVs). Of the 95 respiratory samples tested, 35 (37%) were positive for respiratory viruses other than influenza A/H1N1v virus. Among these infections, we observed 30 monoinfections (HRVs [63%], parainfluenza viruses [PIVs] [20%]), influenza A/H3N2 virus [6%], coronavirus [4%], and HBoV [4%]) and 5 multiple infections, in which HRVs and PIVs were the most frequently detected viruses. No specific single or mixed viral infections appeared to be associated significantly with secondary hospitalization in infectious disease or intensive care departments during the study period (P > 0.5). The use of RT-PCR DNA microarray systems in clinical virology practice allows the rapid and accurate detection of conventional and newly discovered viral respiratory pathogens in patients suffering from ILI and therefore could be of major interest for development of new epidemiological survey systems for respiratory viral infections.
我们前瞻性地检测了 95 份来自 56 名成人和 39 名儿童的鼻拭子或鼻咽抽吸物,这些人在法国甲型 H1N1v 流感大流行的早期(2009 年 10 月)到兰斯大学医学中心(法国北部)就诊,患有流感样疾病(ILI)。使用两种市售的逆转录 PCR(RT-PCR)DNA 微阵列系统组合对呼吸道样本进行了检测,该系统能够快速检测流感 A 病毒株,包括新的 A/H1N1v 株以及 20 种其他常见或新发现的呼吸道病毒。同时,还进行了通用和经典的实时 RT-PCR 检测,以检测同一样本中所有循环的流感 A 病毒株。在 95 份呼吸道样本中,有 30 份(31%)通过 RT-PCR DNA 微阵列和经典实时 RT-PCR 检测均呈甲型 H1N1v 病毒感染阳性。在这些感染中,25 例(83%)为单纯感染,5 例(17%)为多种感染,甲型 H1N1v 病毒与冠状病毒(CoV)、人博卡病毒(HBoV)、呼吸道合胞病毒(RSV)或人鼻病毒(HRV)同时感染。在 95 份呼吸道样本中,有 35 份(37%)除了甲型 H1N1v 病毒之外,还检测到其他呼吸道病毒。在这些感染中,我们观察到 30 例单纯感染(HRV[63%],副流感病毒[PIVs][20%]),甲型 H3N2 病毒[6%],冠状病毒[4%]和 HBoV[4%])和 5 例多种感染,其中 HRV 和 PIVs 是最常检测到的病毒。在研究期间,没有发现特定的单一或混合病毒感染与传染病或重症监护病房的二次住院显著相关(P>0.5)。RT-PCR DNA 微阵列系统在临床病毒学实践中的应用可以快速准确地检测患有 ILI 的患者中的常规和新发现的病毒性呼吸道病原体,因此对于开发新的呼吸道病毒感染的流行病学调查系统可能具有重要意义。